Open access
Open access
Powered by Google Translator Translator

Infectious Diseases (all articles)

COVID-19 and mRNA vaccines—first large test for a new approach

4 Sep, 2020 | 02:08h | UTC

COVID-19 and mRNA Vaccines—First Large Test for a New Approach – JAMA

 

Forty postmortem examinations in COVID-19 Patients: Two distinct pathologic phenotypes and correlation with clinical and radiologic findings

4 Sep, 2020 | 02:05h | UTC

Forty Postmortem Examinations in COVID-19 Patients: Two Distinct Pathologic Phenotypes and Correlation With Clinical and Radiologic Findings – American Journal of Clinical Pathology

 

Commentary on Twitter

 

Opinion: Herd immunity is not a strategy

4 Sep, 2020 | 02:09h | UTC

Herd Immunity Is Not a Strategy – The Atlantic

 

Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic

4 Sep, 2020 | 02:06h | UTC

Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic – Canadian Medical Association Journal

 

Coalition Covid-19 Brazil – Randomized trial: Dexamethasone improves outcomes in patients with Acute Respiratory Distress Syndrome and COVID-19

3 Sep, 2020 | 11:24h | UTC

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial – JAMA

Editorial: Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic

Related studies: Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial – JAMA AND Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial – JAMA

Commentary: Inexpensive Steroids Can Save Lives Of Seriously Ill COVID-19 Patients – NPR

 

Commentary on Twitter

 

Video: Corticosteroids for COVID-19 – New Evidence of Benefit

3 Sep, 2020 | 11:21h | UTC

Corticosteroids for COVID-19 – New Evidence of Benefit – JAMA

 

Meta-analysis: Corticosteroids for critically ill patients with COVID-19

3 Sep, 2020 | 11:23h | UTC

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis – JAMA

Editorial: Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic

Commentaries: Analysis of seven trials finds that corticosteroids reduce risk of death by 20 per cent in critically ill COVID-19 patients – University of Bristol  AND Multiple studies confirm steroids can fight severe COVID-19 – MedicalXpress

 

Commentary on Twitter

 

New WHO Guidance: Corticosteroids for COVID-19

3 Sep, 2020 | 11:20h | UTC

Corticosteroids for COVID-19 – World Health Organization

News Release: WHO updates clinical care guidance with corticosteroid recommendations – World Health Organization

Commentaries: The WHO Now Recommends Cheap Steroids As a Life-Saving Treatment for Severe Covid-19 – Gizmodo AND Inexpensive steroids reduce deaths of hospitalized Covid-19 patients, WHO analysis confirms – STAT

 

Commentary on Twitter

 

[Preprint] Randomized trial: Tocilizumab does not improve clinical status or mortality in hospitalized patients with COVID-19 pneumonia

3 Sep, 2020 | 11:19h | UTC

Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia – medRxiv

 

Covid-19: Study found those younger than 40 had an infection fatality ratio (IFR) of 0.01%; those 60 or older had an IFR of 1.71%

3 Sep, 2020 | 11:18h | UTC

Infection Fatality Ratios for COVID-19 Among Noninstitutionalized Persons 12 and Older: Results of a Random-Sample Prevalence Study – Annals of Internal Medicine

 

Commentary on Twitter

 

Virus in the blood can predict severe COVID-19

3 Sep, 2020 | 11:11h | UTC

Virus in the blood can predict severe COVID-19 – Karolinska Institutet

Original Study: SARS-CoV-2 RNA in serum as predictor of severe outcome in COVID-19: a retrospective cohort study – Clinical Infectious Diseases

 

COVID-19 can wreck your heart, even if you haven’t had any symptoms

3 Sep, 2020 | 11:06h | UTC

COVID-19 Can Wreck Your Heart, Even if You Haven’t Had Any Symptoms – Scientific American

 

IDSA Podcast – Managing patients post-COVID-19: From symptoms to lasting complications

3 Sep, 2020 | 11:08h | UTC

Managing Patients Post-COVID-19: From Symptoms to Lasting Complications – Infectious Diseases Society of America

 

Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection

3 Sep, 2020 | 11:10h | UTC

Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection – University of Cambridge

Original Study: Combined point of care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G Spike Variant – Cell Reports Medicine

 

Fauci says COVID vaccine trials could end early if results are overwhelming

3 Sep, 2020 | 11:02h | UTC

Fauci Says COVID Vaccine Trials Could End Early If Results Are Overwhelming – Kaiser Health News

 

Getting ready for the Covid-19 pandemic: Experience of a Brazilian hospital

3 Sep, 2020 | 11:00h | UTC

Getting Ready for the Covid-19 Pandemic: Experience of a Brazilian Hospital – NEJM Catalyst

 

23 bus passengers contracted coronavirus from 1 infected person. No one was wearing a mask.

2 Sep, 2020 | 10:09h | UTC

23 bus passengers contracted coronavirus from 1 infected person. No one was wearing a mask. – Business Insider

Original Study: Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China – JAMA Internal Medicine

 

Commentary on Twitter

 

New #OpenWho Course: Occupational health and safety for health workers in the context of COVID-19

2 Sep, 2020 | 10:11h | UTC

Occupational health and safety for health workers in the context of COVID-19 – World Health Organization

 

Study: Face shields, masks with valves ineffective against COVID-19 spread

2 Sep, 2020 | 09:55h | UTC

Face Shields, Masks with Valves Ineffective Against COVID-19 Spread – American Institute of Physics

Original Study: Visualizing droplet dispersal for face shields and masks with exhalation valves – Physics of Fluids

 

How many people has the coronavirus killed?

2 Sep, 2020 | 09:59h | UTC

How many people has the coronavirus killed? – Nature

 

Probable evidence of fecal aerosol transmission of SARS-CoV-2 in a high-rise building

2 Sep, 2020 | 10:07h | UTC

Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building – Annals of Internal Medicine

Editorial: SARS-CoV-2: The Growing Case for Potential Transmission in a Building via Wastewater Plumbing Systems

 

Commentary on Twitter

 

Humoral immune response to SARS-CoV-2 in Iceland

2 Sep, 2020 | 09:57h | UTC

Humoral Immune Response to SARS-CoV-2 in Iceland – New England Journal of Medicine

Editorial: The Power of Antibody-Based Surveillance

 

Commentary on Twitter

 

Meta-analysis: Clinical manifestations, risk factors, and maternal and perinatal outcomes of Covid-19 in pregnancy

2 Sep, 2020 | 09:52h | UTC

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis – The BMJ

 

U.S. advisory group lays out detailed recommendations on how to prioritize Covid-19 vaccine

2 Sep, 2020 | 09:46h | UTC

U.S. advisory group lays out detailed recommendations on how to prioritize Covid-19 vaccine – STAT

 

#ESCCongress – [Not Published Yet] First randomized trial backs safety of ACE Inhibitors and ARBs in COVID-19 patients

2 Sep, 2020 | 09:48h | UTC

News Release: First randomised trial backs safety of common heart drugs in COVID-19 patients – European Society of Cardiology

Commentary: Continuing Versus Suspending Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers – BRACE CORONA – American College of Cardiology

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.